John Yetimoglu
CIK: 0002150506
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BHVN
Biohaven Ltd.
Director
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Yetimoglu John
Yetimoglu John (SEC CIK 0002150506) files insider reports with the SEC as Director of Biohaven Ltd. (BHVN).
Signal8 holds 1 ownership filing by Yetimoglu John, a Form 3, filed on Aug 14, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Yetimoglu John's filings is in NEW HAVEN, CT.
Other insiders filing for Biohaven Ltd. (BHVN)
- Gentile Kimberly, SVP, Clinical Operations
- Volles Warren Karl, Chief Legal Officer
- Mehta Kishan, Director
- Bailey Gregory, Director
- Heffernan Michael Thomas, Director
- Antonijevic Irina, Director